Van Hulzen Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50
| Closed | -$6.16K | – | 711 |
|
|
2024
Q4 | $6.16K | Buy |
+50
| New | +$6.16K | ﹤0.01% | 820 |
|
|
2023
Q1 | – | Sell |
-2,631
| Closed | -$419K | – | 314 |
|
|
2022
Q4 | $419K | Buy |
2,631
+109
| +4% | +$17.4K | 0.05% | 195 |
|
|
2022
Q3 | $336K | Sell |
2,522
-3,145
| -55% | -$419K | 0.04% | 200 |
|
|
2022
Q2 | $884K | Sell |
5,667
-412
| -7% | -$64.3K | 0.11% | 118 |
|
|
2022
Q1 | $946K | Buy |
6,079
+207
| +4% | +$32.2K | 0.1% | 118 |
|
|
2021
Q4 | $748K | Buy |
5,872
+1,095
| +23% | +$139K | 0.08% | 138 |
|
|
2021
Q3 | $622K | Buy |
4,777
+1,931
| +68% | +$251K | 0.09% | 121 |
|
|
2021
Q2 | $506K | Buy |
2,846
+189
| +7% | +$33.6K | 0.08% | 147 |
|
|
2021
Q1 | $437K | Buy |
2,657
+40
| +2% | +$6.58K | 0.07% | 159 |
|
|
2020
Q4 | $432K | Buy |
2,617
+98
| +4% | +$16.2K | 0.07% | 159 |
|
|
2020
Q3 | $359K | Buy |
+2,519
| New | +$359K | 0.05% | 172 |
|
|
2020
Q1 | – | Sell |
-10,460
| Closed | -$1.56M | – | 272 |
|
|
2019
Q4 | $1.56M | Buy |
+10,460
| New | +$1.56M | 0.3% | 72 |
|